Afinitor / Votubia (Everolimus)

PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 05/17/2019

Pipeline Type

Newly Marketed

Phase Of Development

Sponsors and Collaborators

Mechanism of Action

Mechanism Description

mTOR Inhibitor

Populations Tested In

Other Resources

Special FDA Designation

Nonprofit or Government Support

N/A

Nonprofit or Government Support Description

N/A

Previous Presentations

Location of Clinical Trials

Clinical Trial link

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.